The University of Oxford announced on Tuesday that it was suspending trials on children of the Covid-19 vaccine that it developed with the Anglo-Swedish laboratory AstraZeneca, pending the opinion of the British regulator.
Read also: Covid-19: complaint from a family after the death of a relative vaccinated with AstraZeneca
"
While there are no concerns regarding the safety of the pediatric clinical trial, we await further information from the MHRA,
" the UK regulator, "
on the rare cases of thrombosis which have been reported in adults, before proceeding with new vaccinations in the trial,
”the British university said in a statement.
